Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 3/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.33 |
| ▸ | GPR6 | P46095 | 4/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 3/20 | 0.31 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.31 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | TNK1 | Q13470 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31542280 | 0.93 | GPR6 (0.35) | ADRA1DADRA1AADRA1BGRM2GPR6 | |
| SCHEMBL31542276 | 0.91 | SLC6A9 (0.35) | CHRM4ADRA1DADRA1AADRA1BCHRM2 | |
| SCHEMBL31542236 | 0.86 | CHRM4 (0.33) | CHRM4ADRA1DADRA1AADRA1BCHRM2 | |
| SCHEMBL31542328 | 0.85 | GRM2 (0.35) | GRM2KCNH2 | |
| SCHEMBL31542307 | 0.83 | SLC6A5 (0.39) | ADRA1DADRA1AADRA1BGPR6KDM1A | |
| SCHEMBL31542228 | 0.82 | GRM2 (0.32) | CHRM4GRM2GPR6 | |
| SCHEMBL31542313 | 0.81 | CRBN (0.33) | CHRM4ADRA1DADRA1AADRA1BGRM2 | |
| SCHEMBL31542278 | 0.80 | ALK (0.37) | KDM1AKCNH2 | |
| SCHEMBL31542195 | 0.80 | CRBN (0.36) | ADRA1DADRA1AADRA1BGPR6PARP1 | |
| SCHEMBL31542290 | 0.78 | KDM1A (0.33) | GPR6KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025062330-A1 | HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS | AURIGENE ONCOLOGY LIMITED (IN) | 2025-03-27 | — | — | WO | disclosed |